SEK 37.0
(-1.99%)
Year | Long Term Debt | Long Term Debt Growth |
---|---|---|
2023 | 623 Thousand DKK | 0.0% |
2022 | - DKK | 0.0% |
2021 | - DKK | -100.0% |
2020 | 57 Thousand DKK | 0.0% |
2019 | - DKK | 0.0% |
2018 | - DKK | 0.0% |
Year | Long Term Debt | Long Term Debt Growth |
---|---|---|
2024 Q1 | - DKK | 0.0% |
2024 Q2 | - DKK | 0.0% |
2023 Q2 | - DKK | 0.0% |
2023 Q1 | - DKK | 0.0% |
2023 FY | 623 Thousand DKK | 0.0% |
2023 Q4 | 623 Thousand DKK | 0.0% |
2023 Q3 | - DKK | 0.0% |
2022 Q4 | - DKK | -100.0% |
2022 FY | - DKK | 0.0% |
2022 Q2 | 69 Thousand DKK | 0.0% |
2022 Q3 | 69 Thousand DKK | 0.0% |
2022 Q1 | - DKK | 0.0% |
2021 Q1 | 14 Thousand DKK | -75.44% |
2021 FY | - DKK | -100.0% |
2021 Q3 | - DKK | 0.0% |
2021 Q4 | - DKK | 0.0% |
2021 Q2 | - DKK | -100.0% |
2020 Q1 | - DKK | 0.0% |
2020 FY | 57 Thousand DKK | 0.0% |
2020 Q4 | 57 Thousand DKK | 0.0% |
2020 Q3 | - DKK | 0.0% |
2020 Q2 | - DKK | 0.0% |
2019 Q3 | - DKK | 0.0% |
2019 Q4 | - DKK | 0.0% |
2019 Q2 | - DKK | 0.0% |
2019 Q1 | - DKK | 0.0% |
2019 FY | - DKK | 0.0% |
2018 FY | - DKK | 0.0% |
2018 Q4 | - DKK | 0.0% |
Name | Long Term Debt | Long Term Debt Difference |
---|---|---|
AddLife AB (publ) | 2.53 Billion SEK | 99.975% |
Biotage AB (publ) | 150 Million SEK | 99.585% |
Bonesupport Holding AB (publ) | 13.22 Million SEK | 95.288% |
Doxa AB (publ) | 3.6 Million SEK | 82.694% |
Elekta AB (publ) | 4.8 Billion SEK | 99.987% |
iZafe Group AB (publ) | 279 Thousand SEK | -123.297% |
Ortivus AB (publ) | 3.57 Million SEK | 82.569% |
Ortivus AB (publ) | 3.57 Million SEK | 82.569% |
Q-linea AB (publ) | 12.9 Million SEK | 95.172% |
S2Medical AB (publ) | - SEK | -Infinity% |
Synsam AB (publ) | 2.02 Billion SEK | 99.969% |